Carl Schmid
Carl Schmid is a prominent advocate in the field of HIV/AIDS research and policy, known for his work with the AIDS Institute, where he emphasizes the importance of accessible treatments for individuals affected by HIV. Recently, he has been in the news for his comments on the newly approved HIV prevention injection, lenacapavir, highlighting its potential to change the landscape of HIV prevention and the moral obligation to provide it to those in need.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Croatia:
Carl Schmid from the Institute studying AIDS stated that it would be inhumane not to provide the new injection to those in need.
9